WHO ICTRP trial
To evaluate the safety and efficacy of liposomal bupivacaine for deep…
ChiCTR2500111089 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500111089 |
|---|---|
| Public title | To evaluate the safety and efficacy of liposomal bupivacaine for deep parasternal intercostal plane block |
| Scientific title | To evaluate the safety and efficacy of liposomal bupivacaine for deep parasternal intercostal plane block |
| Primary sponsor | The First Affiliated Hospital of Nanchang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Postoperative pain in patients undergoing median thoracotomy during cardiac surgery |
| Interventions | LBB group:Patients were subjected to deep intercostal plane block before induction of anesthesia with 40ml, 0.665% bupivacaine liposome (20ml, 266 mg bupivacain;RPB group:Patients before anesthesia induction, using 40 ml, 0.375% ROM pp… |
| Registration date | Oct 24, 2025 |
| Target size | LBB group:24;RPB group:24 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: